Showing results (271-280 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|April 28, 2011
APEX microarray panel for genotyping polymorphisms in cancer chemotherapy and estimation frequencies in a Slovak populationAndrea Soltysova, Gabriel Minarik, Alica Dzurenkova, et al.
Pharmacogenomics|April 23, 2011
Polymorphisms of the LEP, LEPR and HTR2C gene: obesity and BMI change in patients using antipsychotic medication in a naturalistic settingJochem G Gregoor, Jan van der Weide, Harriët M Loovers, et al.
Pharmacogenomics|May 31, 2011
Pharmacogenomics and personalized medicine in clinical practiceVangelis G Manolopoulos, Bryan Dechairo, Alain Huriez, et al.
Pharmacogenomics|May 31, 2011
Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapyLaetitia Albertini, Gérard Siest, Elise Jeannesson, et al.
Pharmacogenomics|March 12, 2011
Resequencing, haplotype construction and identification of novel variants of CYP2D6 in Mexican MestizosAlejandra V Contreras, Tulia Monge-Cazares, Luis Alfaro-Ruiz, et al.
Pharmacogenomics|December 23, 2010
The effect of ESR1 and ESR2 gene polymorphisms on the outcome of rheumatoid arthritis treatment with leflunomideVioletta Dziedziejko, Mateusz Kurzawski, Krzysztof Safranow, et al.
Pharmacogenomics|December 23, 2010
Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbaseMarianthi Georgitsi, Emmanouil Viennas, Vassiliki Gkantouna, et al.
Pharmacogenomics|December 23, 2010
Comparison of warfarin pharmacogenetic dosing algorithms in a racially diverse large cohortJaekyu Shin, Diana Cao
Pharmacogenomics|December 15, 2010
Designing pharmacogenomic studies to be fit for purposeDaniel K Burns, Arlene R Hughes, Aidan Power, et al.
Pharmacogenomics|December 15, 2010
Development and regulatory strategies for drug and diagnostic co-developmentLois M Hinman, Kevin M Carl, Brian B Spear, et al.
Pageof 276